The impact of induction therapy on the risk of posttransplant lymphoproliferative disorder in adult kidney transplant recipients with donor-recipient serological Epstein-Barr virus mismatch
Open Access
- 4 March 2024
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (8) , 1486-1494
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- OPTN/SRTR 2021 Annual Data Report: KidneyAmerican Journal of Transplantation, 2023
- Incidence of Lymphoproliferative Disorders After Renal Transplantation is Down, but the Poor Prognosis Remains. Multicenter 32-Year Cohort Study.Transplantation Proceedings, 2022
- Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A ReviewAmerican Journal of Kidney Diseases, 2021
- Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipientsKidney International, 2018
- Rabbit antithymocyte globulin induction and risk of post-transplant lymphoproliferative disease in adult and pediatric solid organ transplantation: An updateTransplant Immunology, 2015
- New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and AutoimmunityDrugs, 2014
- Lymphoproliferative Disorders After Adult Kidney Transplant: Epidemiology and Comparison of Registry Report With Claims-Based DiagnosesAmerican Journal of Kidney Diseases, 2011
- Posttransplantation Lymphoproliferative Disorder in Kidney and Heart Transplant Recipients Receiving Thymoglobulin: A Systematic ReviewTransplantation Proceedings, 2011
- Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study ReportAmerican Journal of Transplantation, 2004
- Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant RecipientsAmerican Journal of Transplantation, 2004